Compare CNXC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNXC | PRGO |
|---|---|---|
| Founded | 1991 | 1887 |
| Country | United States | Ireland |
| Employees | 455000 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2020 | 2013 |
| Metric | CNXC | PRGO |
|---|---|---|
| Price | $28.00 | $11.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $54.80 | $19.33 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 03-24-2026 | 05-06-2026 |
| Dividend Yield | 5.79% | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $9,825,771,000.00 | $800,000.00 |
| Revenue This Year | $5.29 | N/A |
| Revenue Next Year | $2.49 | $1.02 |
| P/E Ratio | $80.58 | ★ N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $22.05 | $9.23 |
| 52 Week High | $62.14 | $28.44 |
| Indicator | CNXC | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 48.03 |
| Support Level | $24.93 | $10.46 |
| Resistance Level | $34.64 | $12.36 |
| Average True Range (ATR) | 1.39 | 0.47 |
| MACD | 0.60 | 0.01 |
| Stochastic Oscillator | 99.37 | 40.14 |
Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.